SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001144204-15-058915
Filing Date
2015-10-09
Accepted
2015-10-09 16:13:03
Documents
2
Period of Report
2015-05-11
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A v421893_8ka.htm 8-K/A 14562
2 EXHIBIT 10.1 v421893_ex10-1.htm EX-10.1 682649
  Complete submission text file 0001144204-15-058915.txt   698391
Mailing Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017
Business Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-35076 | Film No.: 151153293
SIC: 2835 In Vitro & In Vivo Diagnostic Substances